NEW YORK and AUSTIN, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Terra Innovatum Srl (“Terra Innovatum,” or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. (Nasdaq: GSRT), a publicly traded special purpose acquisition company, today announced that it has accelerated its go-to-market plans for life-saving cancer isotope production with the SOLO™ micro-modular reactor. Terra Innovatum is developing collaborative business models and frameworks to engage with leading i ...